Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lipid-lowering Therapy in COVID-19 Patients with MI
NCT04900155Unknown
- Sponsor
- Penza State University
- Start
- Nov 2020
- Primary completion
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of atorvastatin in hyperlipidemia (2 arms), sponsored by Penza State University. Primary endpoints: Lipid profile assessment at 96 weeks, Assessment of ventricular rhythm disturbances at 96 weeks and 4 more. Status: unknown.
02
Drugs
atorvastatin
03
Conditions
hyperlipidemia
Beyond the preview
Go deeper on NCT04900155.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04900155.